Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease
- Issued Date
- 2020
- Type
- Article
- Keyword
- Immune checkpoint inhibitor; Efcacy; Hyper-progression; Pleura; Albumin
- Publisher
- JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Language
- 영어
- ISSN
- 0171-5216
- Citation Volume
- 146
- Citation Number
- 11
- Citation Start Page
- 3025
- Citation End Page
- 3036
- Files in This Item:
-
-
There are no files associated with this item.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.